Company Close Updates

Gilead Sciences Inc. stock rises Thursday, still underperforms market

Company Logo

Terrence Horan

Referenced Symbols

Shares of Gilead Sciences Inc. GILD, -1.24% inched 0.77% higher to $68.15 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, -0.03% rising 1.71% to 4,438.26 and the Dow Jones Industrial Average DJIA, -0.28% rising 1.56% to 34,912.56. This was the stock's second consecutive day of gains. Gilead Sciences Inc. closed $5.19 short of its 52-week high ($73.34), which the company achieved on August 18th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, -0.72% rose 0.57% to $160.11, Merck & Co. Inc. MRK, -0.43% fell 0.79% to $78.33, and AbbVie Inc. ABBV, -0.89% rose 1.57% to $108.91. Trading volume (7.1 M) eclipsed its 50-day average volume of 6.2 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.